Real-World Evidence for Regulatory Submissions
With changing industry trends and new legislation, having robust real-world evidence (RWE) for your organization is more important than ever.
In this on-demand webinar, you'll hear from experts as they discuss regulatory submissions and how to select quality data. You'll gain insights into PINC AI™ Applied Sciences RWE and how its quality data, which represents over one billion individual patient encounters, can be fit-for-purpose* for your regulatory use.
Topics of discussion will also include:
- Information about recent RWE legislation, including FDA guidance
- Industry trends and resources for filing regulatory submissions
- Case studies from submitting RWE for regulatory submissions, including learnings and challenges
- Leveraging RWE in clinical trials
Chief Commercial Officer, Premier, Inc., PINC AI™ Applied Sciences
Senior Vice President of Government Affairs, Premier, Inc.